45 results

• Infections From Unapproved, Contaminated Stem Cell Treatments Lead To FDA Warning

  December 21, 2018

  Martha Garcia

  An FDA warning letter accuses some drug manufacturers of distributing unapproved stem cell products which caused at least 12 cases of infection due to bacterial contamination.

• JAMA Researcher Failed to Disclose Millions In Industry Payments, Sparking Conflict Of Interest Debate

  November 6, 2018

  Irvin Jackson

  A leading cancer researcher who failed to reveal deep industry ties and millions in payments has been ousted from a leading cancer center and sparked debate about the need for full financial disclosures in scientific research.

• Keytruda, Tecentriq Get New Bladder Cancer Restrictions From FDA

  June 25, 2018

  Irvin Jackson

  The FDA announced new bladder cancer restrictions on the use of Keytruda and Tecentriq, following indications that they could lower survival rates for some patients.

• Keytruda, Tecentriq Side Effects May Decrease Survival Chances In Some Patients: FDA

  May 21, 2018

  Irvin Jackson

  An FDA warning indicates that Keytruda and Tecentriq may decrease the risk of survival in certain metastatic urothelial cancer patients.

• Clinical Trial for Tecentriq-Cotellic Combo Halted After Patient Deaths

  April 13, 2018

  Irvin Jackson

  Roche has temporarily halted a clinical trial of a combination of the cancer drugs Tecentriq and Cotellic following the deaths of several patients involved in the study.

• Taxotere Found To Have More Side Effects, Lower Survival Rate Than Tecentriq: Study

  January 25, 2017

  Irvin Jackson

  A new study raises questions about the safety and effectiveness of Taxotere, which underperformed in both survival rates and side effects when compared to Tecentriq for treatment of lung cancer.

• Xolair Pediatric Use Approved, Despite Health Risks, Heart Concerns

  July 14, 2016

  Irvin Jackson

  Xolair has been approved for use in children ages six to 11, despite concerns over side effects which have led some to suggest it be removed from the market.

• Melanoma Drug Zelboraf Linked to Pancreatitis Risk, Canadian Officials Warn

  February 17, 2015

  Irvin Jackson

  Health Canada has added a pancreatitis warning to the melanoma drug Zelboraf following a safety review.

• Xolair Side Effects May Cause Heart Problems, Cancer: FDA Warns

  September 29, 2014

  Austin Kirk

  The FDA is warning that the asthma drug Xolair may increase the risk of blood vessel problems in the brain and heart.

• Arzerra, Rituxan Could Reactivate Hepatitis B Virus, FDA Warns

  September 26, 2013

  Irvin Jackson

  The FDA has linked the leukemia drugs Rituxan and Arzerra to reactivation of hepatitis B virus and deaths due to liver failure.